Koers Panacos Pharmaceuticals, Inc. Other OTC
Aandelen
PANC
US69811Q1067
Biotechnologie & Medisch Onderzoek
Omzet 2006 | 284K 265K | Omzet 2007 | 180K 168K | Marktkapitalisatie | 42,29 mln. 39,5 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2006 | -38 mln. -35,49 mln. | Nettowinst (verlies) 2007 | -37 mln. -34,55 mln. | EV/omzet 2006 | 504 x |
Nettoliquiditeiten 2006 | 60,4 mln. 56,41 mln. | Nettoliquiditeiten 2007 | 32,58 mln. 30,43 mln. | EV/omzet 2007 | 53,9 x |
K/w-verhouding 2006 |
-5,32
x | K/w-verhouding 2007 |
-1,12
x | Werknemers | - |
Dividendrendement 2006 * |
-
| Dividendrendement 2007 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John R. Barr
CEO | Chief Executive Officer | 67 | - |
Thomas Higgins
DFI | Director of Finance/CFO | 72 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,17% | 102 mld. | |
+2,87% | 96,09 mld. | |
+2,13% | 22,28 mld. | |
-14,77% | 21,4 mld. | |
-8,79% | 18,14 mld. | |
-39,98% | 17,02 mld. | |
-13,21% | 16,09 mld. | |
+8,55% | 13,83 mld. | |
+35,75% | 11,97 mld. |